Interactive Session:
156. Challenging Cases in Transplant: When the ID Expert Says, "What?"
Friday, October 5, 2018: 2:00 PM-3:15 PM
Room: S 206-208
American Society of Transplantation

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • construct an approach to diagnosing and managing challenging infectious disease syndromes occurring in organ and stem cell transplant recipients

Target Audience: Academicians, Clinicians, Fellows, Healthcare workers, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Members-in-training, Nurses, Pharmacists

Tracks: Transplant ID, Trainee, Pediatric ID, Adult ID

Interactive Moderators:  Rachel Miller, MD, Duke University Medical Center and Raymund R. Razonable, MD, FIDSA, Mayo Clinic

Interactive Panelists:  Emily Blumberg, MD, FIDSA, University of Pennsylvania Health System , Lara Danziger-Isakov, MD, MPH, Cincinnati Children's Hospital Medical Center , Carlos Cervera, MD, University of Alberta and Ajit P. Limaye, MD, FIDSA, University of Washington

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 application-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-236-L01-P


R. Miller, scynexis: Investigator , Research support .

R. R. Razonable, None

E. Blumberg, Merck: Grant Investigator and Scientific Advisor , multicenter trial and I am site PI; no financial support for scientific advisory committee and Research support . Bristol Myers Squibb: DSMB member , payment for DSMB work . Glaxo: member of DSMB and Scientific Advisor , no financial support . Shire: Grant Investigator , site PI for multicenter trial .

L. Danziger-Isakov, Merck: Consultant and Research Contractor , Consulting fee and Research support . Ansun BioPharma: Research Contractor , Research support . Roche: Research Contractor , Research support . Chimerix: Research Contractor , Research support . Astellas: Research Contractor , Research support .

C. Cervera, Qiagen: Speaker's Bureau , Speaker honorarium . Merck: Scientific Advisor , Consulting fee .

A. P. Limaye, Merk: Consultant and Investigator , Consulting fee and Research grant . Astellas Pharma Inc.: Consultant and Investigator , Consulting fee . Helocyte Inc.: Consultant , Consulting fee .

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.